There was only one study to suggest the roles of TRAPPC10 until now and showed TRAPPC10 was an oncogenic driver to predict the poor prognosis for breast cancer patients (Pongor et al., 2015), which seemed to be contrast with our results, implying TRAPPC10 may be a new tumor suppressor gene for LSCC. This evidence concerns the gene TRAPPC10 and breast cancer.